We are delighted to receive an honorable mention at the International Society for Pharmaceutical Engineering’s (ISPE) 2014 Facility of the Year Awards for our recently completed cGMP cell culture production facility in Wuxi.
The award was created to showcase the best of each year’s new, state-of-the-art pharmaceutical manufacturing facilities. WuXi is the first company in China to receive this honor. The judging panel praised WuXi’s “very innovative step” to adopt end-to-end single use technology at the plant. The facility’s design and construction are aligned with the most stringent expectations of Western biopharmaceutical manufacturers, the panel concluded. WuXi incorporated two parallel upstream cell culture bioreactor lines with flexible working volumes of 50L to 2,000L and one downstream purification production line into the plant. This arrangement gives WuXi the capacity, flexibility and quality to handle even the most demanding production projects. The facility is designed to meet cGMP standards of the U.S., the EU and China. It has been GMP-audited more than 10 times by global clients.